Dark

NKTR
Nektar Therapeutics
stock NASDAQ

At Close

May 15, 2026 3:59:48 PM EDT

70.79USD-4.756%(-3.54)1,272,965

0.00Bid 0.00Ask 0.00Spread

Pre-market

May 15, 2026 9:25:30 AM EDT

73.50USD-1.117%(-0.83)1,043

After-hours

May 15, 2026 4:48:30 PM EDT

70.62USD-0.247%(-0.17)112,585

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

2.39B

CEO

Howard Robin

Headquarters

San Francisco, California, USA

Industry

Biotechnology

Last Split

Jun 9, 20251for15reverse

AMGN RELL AZN NVS BAX JNJ PFE MRK ALKS XLV

NKTR Stats

Avg. Vol. 10 Day

867,367

Avg. Vol. 30 Day

1,086,134

Employees

509

Market Cap

2,385,969,580

Shares Out.

33,786,032

On/Off Exchange

57%/43%

6 Month Beta

1.10

1 Year Beta

2.79

2 Year Beta

1.88

3 Year Beta

1.96

52 Week Low

7.99

52 Week High

109.00

SMA50

78.80

SMA200

56.55

1 Week

-13.76%

1 Month

-15.92%

3 Month

-4.34%

6 Month

+18.53%

1 Year

+587.30%

2 Year

+161.56%

5 Year

-74.12%

Profile

nektar therapeutics is a leading biopharmaceutical company developing a robust pipeline of novel therapeutics based on its advanced polymer conjugate chemistry technology platform. nektar also partners with the top biopharmaceutical companies to bring new products to market. to date, nektar's technology and drug development expertise have enabled nine approved products for partners, which include leading biopharmaceutical companies.

NKTR Stock Summary

Nektar Therapeutics (NASDAQ:NKTR) stock price today is $70.79, and today's volume is 1,272,965. NKTR is down -4.756% today. The 30 day average volume is 1,086,134. NKTR market cap is 2.39B with 33,786,032 shares outstanding.

document.getElementById("x9tcMk").onerror = function(){this.style.display='none';}; .dark-mode .gkKSZm{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .gkKSZm{ color: #333333; background-color: white; border: 2px solid #333333; }NKTRNektar Therapeuticsstock NASDAQ

NKTR Stock Summary

NKTR
Nektar Therapeutics
stock NASDAQ